Compounds > ondansetron
Page last updated: 2024-11-01

ondansetron and Foot Dermatoses

ondansetron has been researched along with Foot Dermatoses in 3 studies

Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.

Foot Dermatoses: Skin diseases of the foot, general or unspecified.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ruiz Villaverde, R1
Sánchez Cano, D1
Villaverde Gutiérrez, C1
Downs, AM1
Kennedy, CT1
Weisshaar, E1
Gollnick, H1

Other Studies

3 other studies available for ondansetron and Foot Dermatoses

ArticleYear
[Ondansetron. A satisfactory treatment for refractory palmo-plantar pruritus].
    Actas dermo-sifiliograficas, 2006, Volume: 97, Issue:10

    Topics: Adult; Female; Foot Dermatoses; Hand Dermatoses; Humans; Ondansetron; Pruritus; Remission Induction;

2006
Successful treatment of intractable palmoplantar pruritus with ondansetron.
    Archives of dermatology, 1998, Volume: 134, Issue:8

    Topics: Administration, Oral; Female; Follow-Up Studies; Foot Dermatoses; Hand Dermatoses; Humans; Middle Ag

1998
Antipruritic potency of serotonin type 3 (5-HT3) receptor antagonists--a reply.
    Archives of dermatology, 1999, Volume: 135, Issue:5

    Topics: Foot Dermatoses; Hand Dermatoses; Humans; Ondansetron; Pruritus; Serotonin Antagonists

1999